1. Activated T cells and cytokine-induced CD3⁺CD56⁺ killer cells

   • G. D. Schmidt-Wolf
   • R. S. Negrin
   • I. G. H. Schmidt-Wolf

   REVIEW ARTICLE Pages: 51 - 56

2. Idarubicin monotherapy in multiply pretreated leukemia patients: response in relation to P-glycoprotein expression

   • V. Nüssler
   • F. Gieseler
   • W. Wilmanns

   ORIGINAL ARTICLE Pages: 57 - 64

3. Multidrug resistance gene expression in acute myeloid leukemia: Major prognosis significance for in vivo drug resistance to induction treatment

   • M. Hunault
   • D. Zhou
   • J.-P. Marie

   ORIGINAL ARTICLE Pages: 65 - 71

4. Early-onset secondary malignancies after high-dose chemotherapy and autologous hematopoietic stem cell transplantation

   • S. Fetscher
   • J. Finke
   • W. Lange

   ORIGINAL ARTICLE Pages: 73 - 77

5. Alternating mini-BEAM/ESHAP as salvage therapy for refractory non-Hodgkin's lymphomas

   • M. D. Caballero
   • M. L. Amigo
   • J. F. San Miguel

   ORIGINAL ARTICLE Pages: 79 - 82

6. The putative role of arylsulfatase in interleukin-2- mediated cytotoxicity and interleukin-7-mediated bactericidal activity of natural killer cells

   • A. Toren
   • M. Gadish
   • A. Nagler

   ORIGINAL ARTICLE Pages: 83 - 87

7. Acquired factor VIII inhibitors in nonhemophilic patients

   • D. Söhngen
   • C. Specker
   • W. Schneider

   ORIGINAL ARTICLE Pages: 89 - 93

8. Myelodysplastic syndrome presenting as third malignancy after non-Hodgkin's lymphoma and osteosarcoma

   • M. Kubota
   • M. Sawada
   • K. Furusho

   CASE REPORT Pages: 95 - 97

9. Cytomegalovirus-associated myelodysplasia and thrombocytopenia in an immunocompetent adult

   • M. Miyahara
   • Y. Shimamoto
   • K. Ono

   CASE REPORT Pages: 99 - 101